Streetwise Tools & Diagnostics Articles
Microbot Shares Soar on Claims It Has Created the World's First Fully Disposable Endovascular Robotic System
Source: Streetwise Reports (12/24/19)
Shares of Microbot Medical traded 70% higher after the company reported that in January 2020 it will unveil the world's first fully disposable robotic system for endovascular procedures. The firm claims that its breakthrough technology features compact design, remote operation capabilities and an integrated "One & Done" tool to democratize endovascular procedures.
More >
Reliq Re-establishes Itself as Community Care Technology Leader Amidst Sweeping Federal Medicare/Medicaid Changes
Source: Knox Henderson for Streetwise Reports (11/13/19)
A shift in the industry leads to big new contracts and parabolic stock performance for this small cap.
More >
Castle Biosciences Shares Storm Higher After Quadrupling Q3 YoY Revenue
Source: Streetwise Reports (11/12/19)
Shares of melanoma and other skin cancers diagnostic firm Castle Biosciences Inc. traded more than 15% higher today after the firm announced Q3/19 financial and operational results.
More >
Dexcom Posts 49% YoY Revenue Growth, Sending Shares to 52-Week High
Source: Streetwise Reports (11/7/19)
Glucose monitoring systems developer Dexcom's shares traded 30% higher today after releasing Q3/19 earnings and raising full-year 2019 guidance.
More >
Fulgent Genetics Hits 52-Week High After Posting 84% Q3 Revenue Increase
Source: Streetwise Reports (11/5/19)
Fulgent Genetics shares traded more than 40% higher today after the company reported record revenue in Q3/19. The firm noted that it completed a record 20,697 billable tests in Q3/19, up 272% over the same period last year.
More >
Navidea Shares Jump 60% on Phase 2b Rheumatoid Arthritis Trial Results
Source: Streetwise Reports (10/29/19)
Shares of Navidea Biopharmaceuticals traded 60% higher today on extremely high relative volume after the firm released data from its Phase 2b Rheumatoid Arthritis Tc 99m Tilmanocept Planar Imaging study.
More >
New Data Could Drive Use of Pancreatic Cancer Early Detection Test
Source: Streetwise Reports (10/29/19)
The recent results and their implications are provided in an H.C. Wainwright & Co. report.
More >
Technical Analyst Expects Health Technologies Firm to Break Higher
Source: Clive Maund for Streetwise Reports (10/14/19)
Technical analyst Clive Maund outlines the reasons this stock might break higher.
More >
Guardant Health Reports Quarterly Revenue Up 178%
Source: Streetwise Reports (8/7/19)
Guardant Health Inc. reported strong growth for Q2/19 versus the same period last year and raised its full-year 2019 revenue guidance to $180–190 million.
More >
Biotech's Mosquito Test 'Gains Market Acceptance'
Source: Streetwise Reports (8/2/19)
This West Nile virus test and others including cancer diagnostic tests in the Utah company's pipeline are discussed in an H.C. Wainwright & Co. report.
More >
Tandem Increases Unit Sales of t:slim X2 Insulin Pumps 290% Worldwide
Source: Streetwise Reports (8/2/19)
Tandem Diabetes Care's second quarter earnings highlighted a 290% increase in unit sales of its t:slim X2 insulin pumps that feature integrated continuous glucose monitoring and remote software update capability.
More >
Technical Analyst: Medical Device Stock Looking Set to Reverse
Source: Clive Maund for Streetwise Reports (7/12/19)
Technical analyst Clive Maund charts the stock of this company that has developed a device that uses a special light that visualizes cancer during minimally invasive surgery.
More >
Health Technology Company Recuperating Well
Source: Clive Maund for Streetwise Reports (7/3/19)
Technical analyst Clive Maund charts a medical technology firm and explains why he believes it is an interesting speculative play.
More >
Bacteria Test Developer Reiterates Revenue Should Double in 2019
Source: Streetwise Reports (6/5/19)
The product expected to drive that outcome is discussed in an H.C. Wainwright & Co. report.
More >
Healthcare Firm Partners on Genetic Testing for Cannabis, Medication Responses
Source: Streetwise Reports (6/3/19)
The offering should facilitate a more individualized treatment plan for patients.
More >
Health Tech Firm to Pilot Artificial Intelligence-Powered Patient Monitoring Tool
Source: Streetwise Reports (4/24/19)
This effort is one way the company can innovatively offer patients care.
More >
Biotech Achieves Development Milestone for Blue Light Imaging System
Source: Streetwise Reports (4/5/19)
The surgical imaging firm continues to advance its first medical device toward commercialization.
More >
Innovative Healthcare Tech Firm to Acquire Two Vancouver Pharmacies
Source: Streetwise Reports (4/3/19)
The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app.
More >
Firm Signs Paid Pilot Agreements to Test Telemedicine Platform in 5 States
Source: Streetwise Reports (3/30/19)
With this development, the Canadian company further expands its U.S. footprint.
More >
Premier Health Group Adding Medical Cannabis Support Tool
Source: Streetwise Reports (3/27/19)
This clinical decision support software integration is the first of its kind, according to the company.
More >
5 Small-Caps on Fund Manager Steve Palmer's Radar Screen
Source: Streetwise Reports (3/19/19)
Steve Palmer, Founding Partner, President and Chief Investment Officer for AlphaNorth Asset Management, talks about a handful of companies in diverse industries that have his attention.
More >
Health Tech Firm Completes Enrollment for Female Sexual Function Trial
Source: Streetwise Reports (3/15/19)
A Ladenburg Thalmann report reviewed the study design and purpose.
More >
Anixa Doesn't Disappoint
Source: Daniel Carlson for Streetwise Reports (1/29/19)
Daniel Carlson of Tailwinds Research explains why he has designated this company his 2019 stock of the year.
More >
Biotech Enters License Agreement to Validate Biomarker as Alternative NASH Diagnostic
Source: Streetwise Reports (1/5/19)
The background and justification for the deal was covered in an H.C. Wainwright & Co. report.
More >
Telehealth Services Provider's Positive Q3/18 Results Reflect 'Robust Growth Rate'
Source: Streetwise Reports (12/12/18)
A William Blair report reviewed the firm's operational and financial numbers for the period.
More >


